千红制药(002550.SZ)：上半年净利润2.58亿元 同比增长41.17%

Core Viewpoint - Qianhong Pharmaceutical (002550.SZ) reported a slight increase in revenue for the first half of 2025, with a notable rise in net profit, indicating strong financial performance despite modest revenue growth [1] Financial Performance - The company achieved operating revenue of 862 million yuan, representing a year-on-year growth of 0.72% [1] - Net profit attributable to shareholders reached 258 million yuan, showing a significant year-on-year increase of 41.17% [1] - The net profit excluding non-recurring gains and losses was 199 million yuan, reflecting a year-on-year growth of 10.71% [1] - Basic earnings per share were reported at 0.2065 yuan [1]